|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients 显示文摘 | Weijmer MC van den Dorpel MA Van de Ven PJ | 2005 | J Am Soc Nephrol2005，16，9： | 1 |
| 2 | Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients显示文摘 | Weijmer MC van den Dowel MA Van de Ven PJ | 2005 | J Am Soc Nephrol2005，16，9： | 1 |
| 3 | Initiating CAPD with a regimen low in glucose and glucose degradation products, with icodextrin and amino acids (NEPP) is safe and efficacious 显示文摘 | le PCY Welten AG Weijmer MC | 2005 | Petit Dial Int2005，25，3： | 1 |
| 4 | A contrast calsis显示文摘 | Beckers EAM Strack van Sch :jnel RIM Weijmer MC | 2000 | Lancet2000，356，9233： | 1 |
| 5 | Randomized,clinical trial comparison of trisodium citrate 30%and heparin as catheter-locking solution in hemodialysis patients显示文摘 | Weijmer MC van den Dorpel MA Van de Yen PJ | 2005 | J Am Soc Nephrol2005，16，9： | 1 |
| 6 | Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients 显示文摘 | Weijmer MC van den Dorpel MA Van de Ven PJ | 2005 | J Am Soc Nephrol2005，16，： | 1 |
| 7 | Prospective follow - up of a novel design haemodialysis catheter; lower infection rates and improved survival显示文摘 | WEIJMER MARCEL C VERVLOET MARC G TER WEE | 2008 | Nephrology Dialysis Transplantation2008，23，： | 1 |
| 8 | Compared to tunneled cuffed hemodialysis catheters,temporary untunneled catheters are associated with more complications already within 2 weeks of use显示文摘 | Weijmer MC Vervloet MG ter Wee PM | 2004 | Nephrol Dial Transplant2004，19，： | 1 |
| 9 | Random ized,clinical trial comparison of trisodium citrate 30 and heparin as catheter locking solution in hemodialysis patients显示文摘 | Weijmer MC van den Dorpel MA van de Ven PJ | 2005 | J Am Soc Nephrol2005，16，： | 1 |
| 10 | A contrast crisis 显示文摘 | Beckers E A Strack van Schijndel R J Weijmer M C | 2000 | Lancet2000，356，9233： | 1 |
| 11 | A contrast crisis显示文摘 | Beckers EA Strack van Schijndel RJ Weijmer MC | | 0，，9233： | 1 |
| 12 | A contrast caisis显示文摘 | Beckers EMA Strack van Schijnel RIM Weijmer MC | 2000 | Lancet2000，356，9233： | 1 |
| 13 | Ran- domized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis pa- tients 显示文摘 | Weijmer MC van den Dorpel/VIA Van de Ven PJ | 2005 | J Am Soc Nephro12005，16，9： | 1 |
| 14 | Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients显示文摘 | Weijmer MC | 2005 | J Am Soc Nephrol2005，16，9： | 1 |
| 15 | Randomized, clinical trial comparison of trisodium ci trate 30% and heparin as catheter-locking solution in hemodialysis patients显示文摘 | Weijmer MC van den Dorpel MA Van de-gen PJ | 2005 | J Am Soc Nephrol2005，16，9： | 1 |
| 16 | Initiating CAPD with a regimen low in glucose and glucose degradation products,with icodextrin and amino acids(NEPP)is safe and efficacious显示文摘 | le Poole CY Welten AG Weijmer Mc | 2005 | Perit Dial Int2005，253，： | 1 |
| 17 | Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients显示文摘 | Weijmer MC den Dorpel MA v Van de Ven PJ et a1 | 2005 | J Am Soc Nephrol2005，16，： | 1 |
| 18 | Randomized, clinical trial comparison of trisodium cit- rate 30% and heparin as catheter-locking solution in he- modialysis patients显示文摘 | Weijmer M C van den Dorpel M A Van de Ven P J | 2005 | J Am Soc Nephrol2005，16，9： | 1 |
| 19 | Randomized, clinical trial comparison of trisodium citrate 30% and heparin as cathe- ter-locking solution in hemodialysis patients 显示文摘 | Weijmer MC van den Dorpel MA van de Ven PJ | 2005 | J Am Soc Nephrol2005，16，9： | 1 |
| 20 | Randomized, clinical trial comparison of trisodium ci- trate 30% and heparin as catheter-locking solution in hemodialysis patients显示文摘 | Weijmer MC van den Dorpel MA Van de Yen PJ | 2005 | J Am Soc Nephrol2005，16，9： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员